InvestorsHub Logo
Followers 6
Posts 4111
Boards Moderated 0
Alias Born 12/14/2009

Re: None

Friday, 02/08/2019 12:49:16 PM

Friday, February 08, 2019 12:49:16 PM

Post# of 108192
The prelim NEO trial data explains three things:

1) the current market valuation of Advaxis (fair value)

2) why Amgen decided further investment was not worth it

2) why it is now necessary to add a PD1 to the NEO and Hot trials
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News